Laboratoires Euromedis Société anonyme (FRA:61R)
Germany flag Germany · Delayed Price · Currency is EUR
3.890
+0.060 (1.57%)
Last updated: Nov 28, 2025, 8:11 AM CET

FRA:61R Statistics

Total Valuation

FRA:61R has a market cap or net worth of EUR 11.38 million. The enterprise value is 3.68 million.

Market Cap11.38M
Enterprise Value 3.68M

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date Dec 24, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 2.84M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 994,939

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.29
PB Ratio 0.69
P/TBV Ratio 0.69
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.67
EV / Sales 0.10
EV / EBITDA 2.04
EV / EBIT 4.08
EV / FCF n/a

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.51.

Current Ratio 1.84
Quick Ratio 1.30
Debt / Equity 0.51
Debt / EBITDA 4.67
Debt / FCF n/a
Interest Coverage 1.64

Financial Efficiency

Return on equity (ROE) is -28.35% and return on invested capital (ROIC) is 2.02%.

Return on Equity (ROE) -28.35%
Return on Assets (ROA) 1.32%
Return on Invested Capital (ROIC) 2.02%
Return on Capital Employed (ROCE) 4.80%
Revenue Per Employee 877,140
Profits Per Employee -124,479
Employee Count44
Asset Turnover 0.91
Inventory Turnover 3.64

Taxes

In the past 12 months, FRA:61R has paid 130 in taxes.

Income Tax 130
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.17% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -13.17%
50-Day Moving Average 3.86
200-Day Moving Average 3.96
Relative Strength Index (RSI) 58.66
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:61R had revenue of EUR 38.59 million and -5.48 million in losses.

Revenue38.59M
Gross Profit 1.48M
Operating Income 902,684
Pretax Income -5.48M
Net Income -5.48M
EBITDA 1.80M
EBIT 902,684
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 16.11 million in cash and 8.41 million in debt, giving a net cash position of 7.70 million.

Cash & Cash Equivalents 16.11M
Total Debt 8.41M
Net Cash 7.70M
Net Cash Per Share n/a
Equity (Book Value) 16.58M
Book Value Per Share n/a
Working Capital 17.60M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 3.84%, with operating and profit margins of 2.34% and -14.19%.

Gross Margin 3.84%
Operating Margin 2.34%
Pretax Margin -14.19%
Profit Margin -14.19%
EBITDA Margin 4.67%
EBIT Margin 2.34%
FCF Margin n/a

Dividends & Yields

FRA:61R does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -48.14%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:61R has an Altman Z-Score of 1.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.85
Piotroski F-Score 2